Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyglucoferron versus Ferric Carboxymaltose versus oral iron for preoperative iron deficiency anemia in elective non-cardiac surgery
2017-003416-38Phase 3Completed
- Sponsor
- Fraunhofer-Gesellschaft
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ferric carboxymaltose and ferrous sulfate in iron deficiency anemia (IDA) (3 arms), sponsored by Fraunhofer-Gesellschaft. Primary endpoint: Hemoglobin response before surgery. Started Nov 2017; status: completed.
02
Drugs
ferric carboxymaltoseferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2017-003416-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003416-38.